Concepedia

David Proudman

DP

4

Publications

204

Citations

4

H-Index

2020

Active since

Affiliations

Analysis Group (United States)(Current)

Menlo School

David Proudman is an author at Analysis Group (United States) specializing in medicine, breast cancer, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2020–2024

4

Publications

4

The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers

David Proudman, Dave Nellesen · PharmacoEconomics · 2021 · 160 citations · Full text

Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score-matched analysis of E7438-G000-101 trial outcomes

David Proudman, Deepshekhar Gupta, Dave Nellesen et al. · Oncotarget · 2022 · 16 citations · Full text

Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis

Brent D. Fulton, David Proudman, Hannah A. Sample et al. · PLoS ONE · 2020 · 14 citations · Full text

Short-term risk of recurrence in patients (pts) with HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in randomized clinical trials (RCTs): A meta-analysis.

Giuseppe Curigliano, Eva Ciruelos, Kevin Kalinsky et al. · Journal of Clinical Oncology · 2024 · 14 citations

, , +20

Rows per page

1–4 of 4